Winner Medical
Winner Medical is the leading manufacturer for disposable wound-care and surgical products in China.
Winner Medical, founded in August 2000, is the Chinese manufacturer of disposable wound-care and surgical products focusing on manufacturing, R&D, and marketing cotton-based medical dressings and medical disposables, as well as consumer products under the "Purcotton" brand. The founder is Li Jianquan. Listed on the Shenzhen Stock Exchange in September 2020, the company's major shareholders include Winner Medical Group, Inc, Beijing Sequoia Xinyuan Equity Investment Center (L.P.), Shenzhen Kangsheng Investment Limited Partnership. Rivals with direct and indirect competition with Winner Medical are C&S Paper, Zhende Medical, Allmed Medical Products.
F-star to be acquired by China biopharmaceutical with USD 161million
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
BeiGene: a Vast Opportunity Lies Ahead – But We Remain Cautious
BeiGene, a leader in China's novel pharmaceutical industry, recently received approval in Kuwait, Bahrain, and Qatar for its medication BRUKINSA (zanubrutinib). Previous contracts with major biopharma have produced substantial licensing income, but they did not lessen BeiGene's financial burden.
Jun 24, 2022 12:13 PM
East China medicine "liraglutide" goes to sea
Research
Technology, Healthcare, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care
Robust medical: it plans to acquire the controlling equity of Hunan Ping An medical equipment
Mask protection unit rose in the afternoon
NK Celltech Receives a Series A Round of Funding Worth More Than CNY 100 Million
NK Celltech recently received a Series A round of funding totaling more than CNY 100 million. Huagai Capital led this round of funding, which was followed by CASVC, Unifortune, 呈益资本, Sirius Capital, and QJ Capital.
Jul 01, 2022 03:58 PM
Imber: the shareholder Ruan bin has completed the reduction of 337500 shares and plans to continue to reduce no more than 1.32% of the shares
Robust medical: by the end of October, 1159400 shares had been repurchased
Robust medical treatment: affected by the recent spread of delta virus strain, the company's demand for protective products such as masks and protective clothing has increased significantly
Xinxiang Chemical Fiber: some production workshops of viscose filament are temporarily shut down due to water inflow